References
- U. Muhl-Kufner, H. Ensinger, J. Mierau, F. J. Kuhn, E. Lehr and E. Muller, Unsymmetrisch substituierte Xanthine, DE 43 25 254 A1, Jul 28, 1993; ref. Chem. Abstr.121 (1994) 280676s.
- M. Rother, B. Kittner, K. Rudolphi, M. Rössner and K. H. Labs, HWA 285 (propentofylline) - a new compound for the treatment of both vascular dementia and dementia of the Alzheimer type, Ann. N. Y. Acad. Sci.777 (1996) 404--409.
- N. Danchev, Al. Zlatkov and Pl. Peikov, Synthesis, toxicological and pharmacological investigations of 8-basic substituted derivatives of caffeine, Compt. Rend. Bulg. Acad. Sci.48 (1995) 119--122.
- AutoNom 2000 Add-in for MDL ISIS/Draw. Software for generating IUPAC chemical names. MDL Information Systems; http://www.mdli.com
- J. Gagauzov, P. Peikov, D. Davkov and K. Sharankov, Synthesis of 8-bromomethylxanthines, Pharmacia (Sofia)37 (1987) 8--10.
- Acute Oral Toxicity — Up-and-Down Procedure, OECD Organization for Economic Cooperation and Development (2001). Guideline for the Testing of Chemicals 425, Paris 2001; http://www.epa.gov/oppfead1/harmonization/docs/E425guideline.pdf.
- C. Caillard, A. Menn, M. Plotkine and P. Rossignol, Do anticonvulsant drugs exert protective effect against hypoxia? Life Sci.16 (1975) 1607--1612; DOI: 10.1016/0024-3205(75)90078-8.
- L. Roshtina and R. Ostrovskaya, Effect of piracetam on the body resistance to hypoxia, Farmakol. Toksikol.44 (1981) 210--213.
- E. Sumina, V. Shugaev and V. Shugaev, The mechanism of circulatory hypoxia in acute sodium fluoride poisoning, Farmakol. Toksikol.41 (1978) 480--482.
- W. Persch and R. Beyerle, Mercury - containing xanthine compounds, Ger. Pat. 1,005,517, Apr 4, 1957; ref. Chem. Abstr.53 (1957) 18070d.
- B. A. Prijmenko, N. I. Romanenko, I. V. Fedulova, L. P. Ostrenko, A. Chervinskij and S. N. Garmash, Synthesis and biological properties of derivatives of (3-methyl-7-alkylxanthinyl-8)-thioacetic acids, Khim. Pharm. Zh.20 (1986) 1322--1324.
- H. Wiener and C. Gilon, An improved method for the catalytic preparation of t-butyl esters of carboxylic and fatty acids, J. Mol. Catal.37 (1986) 45--52.
- D. F. De Tar and R. Silverstein, Reactions of carbodiimides. I. Mechanisms of the reactions of acetic acid with dicyclohexylcarbodiimide, J. Am. Chem. Soc.88 (1966) 1013--1016; DOI: 10.1021/ja00957a027.
- D. F. De Tar and R. Silverstein, Reactions of carbodiimides. II. Reactions of dicyclohexylcarbodiimide with carboxylic acids in the presence of amines and phenols, J. Am. Chem. Soc.88 (1966) 1020--1024; DOI: 10.1021/ja00957a028.
- D. L. Bowton, D. A. Stump, D. S. Prough, D. S. Lefkowitz and L. Coker, Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease, Stroke20 (1989) 1662--1666.
- C. D. Nicholson, Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia, Psychopharmacology101 (1990) 147--159; DOI: 10.1007/BF02244119.
- B. L. Eun, X. H. Liu and J. D. E. Barks, Pentoxifylline attenuates hypoxic-ishemic brain injury in immature rats, Ped. Res.47 (2000) 73--78.